Have a personal or library account? Click to login
Smokers' Characteristics Associated with Successful Smoking Cessation Undergoing Pharmacotherapy in Slovenia Cover

Smokers' Characteristics Associated with Successful Smoking Cessation Undergoing Pharmacotherapy in Slovenia

Open Access
|Sep 2024

References

  1. Peacock A, Leung J, Larney S, Colledge S, Hichman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–1926. doi: 10.1111/add.14234.
  2. Cheung CM, Vardavas CI, Filippidis FT. Factors associated with abstinence after a recent smoking cessation attempt across 28 European Union member states. Tob Prev Cessat. 2020;7:5. doi: 10.18332/tpc/132123.
  3. L Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–1249. doi: 10.1016/S0140-6736(20)30752-2.
  4. Su Z, McDonnell D, Cheshmehzangi A, Ahmad J, Šegalo S, da Veiga CP. A call to ban the sale of tobacco products. Front Public Health. 2022 10;10:904971. doi: 10.3389/fpubh.2022.904971.
  5. Dai X, Gil GF, Reitsma MB, Ahmad NS, Anderson JA, Bisignano C, et al. Health effects associated with smoking: A Burden of Proof study. Nat Med. 2022;28(10):2045–2055. doi: 10.1038/s41591-022-01978-x.
  6. Liu H, Qi Q, Duan Y, Ma C, Zhou C. Sex and macroeconomic differences and 320 trends in early attempts at cigarette smoking among adolescents: Findings from 147 321 countries. BMC Med. 2022;20(1):311. doi: 10.1186/s12916-022-02512-z.
  7. Rezaei S, Akbari Sari A, Arab M, Majdzadeh R, Mohammad Poorasl A. Economic burden of smoking: a systematic review of direct and indirect costs. Med J Islam Repub Iran. 2016 Jul 13;30:397.
  8. Villanti AC, West JC, Klemperer EM, Graham AL, Mays D, Mermelstein RJ, et al. Smoking-cessation interventions for U.S. young adults: Updated systematic review. Am J Prev Med. 2020;59(1):123–136. doi: 10.1016/j.amepre.2020.01.021.
  9. Giulietti F, Filipponi A, Rosettani G, Giordano P, Iacoacci C, Spannella F et al. Pharmacological approach to smoking cessation: An updated review for daily clinical practice. High Blood Press Cardiovasc Prev. 2020;27(5):349–362. doi: 10.1007/s40292-020-00396-9.
  10. El Asmar ML, Laverty AA, Vardavas CI, Filippidis FT. How do Europeans quit using tobacco, e-cigarettes and heated tobacco products? A cross-sectional analysis in 28 European countries. BMJ Open. 2022;12(4):e059068. doi: 10.1136/bmjopen-2021-059068.
  11. Girvalaki C, Filippidis FT, Kyriakos CN, Driezen P, Herbeć A, Mons U et al. Perceptions, predictors of and motivation for quitting among smokers from six European countries from 2016 to 2018: Findings from EUREST-PLUS ITC Europe surveys. Int J Environ Res Public Health. 2020;17(17):6263. doi: 10.3390/ijerph17176263.
  12. Gram IT, Antypas K, Wangberg SC, Løchen ML, Larbi D. Factors associated with predictors of smoking cessation from a Norwegian internet-based smoking cessation intervention study. Tob Prev Cessat. 2022;8:38. doi: 10.18332/tpc/155287.
  13. Plurphanswat N, Rodu B. Why can't smokers quit? Longitudinal study of smokers in the US using the Population Assessment of Tobacco and Health (PATH) waves 1 to 5. Addict Behav Rep. 2023;18:100517. doi: 10.1016/j.abrep.2023.100517.
  14. Kim YJ. Predictors for successful smoking cessation in Korean adults. Asian Nurs Res. 2014;8(1):1–7. doi: 10.1016/j.anr.2013.09.004.
  15. Lim KH, Cheong YL, Sulaiman N, Yah XY, Mahadzir ME, Lim JH et al. Agreement between the Fagerström test for nicotine dependence (FTND) and the heaviness of smoking index (HSI) for assessing the intensity of nicotine dependence among daily smokers. Tob Induc Dis. 2022;20:105. doi: 10.18332/tid/155376.
  16. Fagerström K, Russ C, Yu CR, Yunis C, Foulds J. The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: A pooled analysis of varenicline clinical trial data. Nicotine Tob Res. 2012;14(12):1467–73. doi: 10.1093/ntr/nts018.
  17. Fidler JA, Shahab L, West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction. 2011;106(3):631–8. doi: 10.1111/j.1360-0443.2010.03226.x.
  18. Levshin V, Slepchenko N. Determinants of smoking cessation and abstinence in a Russian smoking-cessation center. Tob Prev Cessat. 2017;3:124. doi: 10.18332/tpc/76623.
  19. Oreskovic T, Percac-Lima S, Ashburner JM, Tiljak H, Rifel J, Klemenc Ketiš Z et al. Cytisine versus varenicline for smoking cessation in a primary care setting: A randomized non-inferiority trial. Nicotine Tob Res. 2023;25(9):1547–1555. doi: 10.1093/ntr/ntad065.
  20. Mesarič J, Novak-Mlakar D, Hočevar T, Koprivnikar H, Sedlar Kobe N. Priročnik Svetovanje za opuščanje kajenja. Ljubljana: Inštitut za varovanje zdravja Republike Slovenije; 2013. 66 p.
  21. Hock ES, Franklin M, Baxter S, Clowes M, Chilcott J, Gillespie D. Covariates of success in quitting smoking: A systematic review of studies from 2008 to 2021 conducted to inform the statistical analyses of quitting outcomes of a hospital-based tobacco dependence treatment service in the United Kingdom. NIHR Open Res. 2023;3:28. doi: 10.3310/nihropenres.13427.2.
  22. Kim Y, Lee JS, Cho WK. Factors associated with successful smoking cessation according to age group: Findings of an 11-year Korea National Survey. Int J Environ Res Public Health. 2021;18(4):1576. doi: 10.3390/ijerph18041576.
  23. Hughes R, Davies GR. Predicting progression to treatment using the Fagerström score in a free NHS smoking cessation programme. Int J Tuberc Lung Dis. 2019;23(5):606–611. doi: 10.5588/ijtld.18.0532.
  24. Mersha AG, Eftekhari P, Bovill M, Tollosa DN, Gould GS. Evaluating level of adherence to nicotine replacement therapy and its impact on smoking cessation: A systematic review and meta-analysis. Arch Public Health. 2021;79(1):26. doi: 10.1186/s13690-021-00550-2.
  25. Hays JT, Leischow SJ, Lawrence D, Lee TC. Adherence to treatment for tobacco dependence: Association with smoking abstinence and predictors of adherence. Nicotine Tob Res. 2010;12(6):574–81. doi: 10.1093/ntr/ntq047.
  26. Falba T, Jofre-Bonet M, Busch S, Duchovny N, Sindelar J. Reduction of quantity smoked predicts future cessation among older smokers. Addiction. 2004;99(1):93–102. doi: 10.1111/j.1360-0443.2004.
  27. Hyland A, Levy DT, Rezaishiraz H, Hughes JR, Bauer JE, Giovino GA et al. Reduction in amount smoked predicts future cessation. Psychol Addict Behav. 2005;19(2):221–5. doi: 10.1037/0893-164X.19.2.221.
  28. Noor F, Koegelenberg CFN, Esterhuizen TM, Irusen EM. Predictors of treatment success in smoking cessation with varenicline combined with nicotine replacement therapy v. varenicline alone. S Afr Med J. 2017;108(1):45–49. doi: 10.7196/SAMJ.2017.v108i1.12671.
  29. Kale D, Gilbert HM, Sutton S. Are predictors of making a quit attempt the same as predictors of 3-month abstinence from smoking? Findings from a sample of smokers recruited for a study of computer-tailored smoking cessation advice in primary care. Addiction. 2015;110(10):1653–64. doi: 10.1111/add.12972.
  30. Lindson N, Theodoulou A, Ordóñez-Mena JM, Fanshawe TR, Sutton AJ, Livingstone-Banks J et al. Pharmacological and electronic cigarette interventions for smoking cessation in adults: Component network meta-analyses. Cochrane Database Syst Rev. 2023;9(9):CD015226. doi: 10.1002/14651858.CD015226.pub2.
  31. Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP. Effect of cytisine vs varenicline on smoking cessation: A randomized clinical trial. JAMA. 2021;326(1):56–64. doi: 10.1001/jama.2021.7621.
  32. Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018;72(25):3332–3365. doi: 10.1016/j.jacc.2018.10.027.
  33. Cencelj Arnez R, Besic N, Mavric Z, Mozetic A, Zagar T, Homar V et al. Evaluation of an early individualized integrated rehabilitation program versus standard rehabilitation program for smoking cessation in 115 smokers among 467 female breast cancer patients 2019–2021 in Slovenia. Med Sci Monit. 2023;29:e942272. doi: 10.12659/MSM.942272.
DOI: https://doi.org/10.2478/sjph-2024-0024 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 180 - 187
Submitted on: Mar 21, 2024
|
Accepted on: Jul 22, 2024
|
Published on: Sep 23, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Marko Drešček, Špela Miroševič, Janez Rifel, Stjepan Orešković, Igor Švab, Vesna Homar, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.